• HR Repair Profiling Predicts PARP Response in Mesothelioma M

  2026-06-15

  Borchert et al. (2019) revealed that gene expression patterns of the homologous recombination repair (HRR) pathway, especially BRCAness-associated defects, stratify malignant pleural mesothelioma (MPM) for susceptibility to PARP inhibition. Their work highlights potential for gene-guided, combination chemotherapy strategies to improve outcomes in this aggressive cancer.

• ATM Inhibition and Fenofibrate Synergy in Ovarian Cancer Cel

  2026-06-15

  This study demonstrates that combining ATM kinase inhibition with fenofibrate, a metabolic modulator, induces senescence synergistically in high grade serous ovarian cancer (HGSOC) cells. The findings reveal metabolic vulnerabilities in HR-proficient HGSOC, pointing to new combinatorial therapeutic strategies beyond DNA repair targeting.

• Mutant p53 Reactivation: TRAP-1 Small Molecule Restores Func

  2026-06-14

  A recent study reports the discovery of TRAP-1, a small molecule that specifically reactivates the Y220C mutant form of p53 by inducing a ternary complex with BRD4. This approach demonstrates a new paradigm for restoring tumor suppressor function in cells carrying p53 mutations, with significant implications for targeted cancer therapy.

• AICAR and AMPK: Strategic AMPK Activation in Translational R

  2026-06-13

  This thought-leadership article explores how AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside), a potent cell-permeable AMPK activator, provides translational researchers with mechanistic leverage to dissect and therapeutically modulate metabolic stress, inflammation, and mitochondrial dysfunction. Bridging breakthroughs in sarcopenic obesity and mitophagy with practical experimental workflows, we chart a credible, evidence-backed path from bench to bedside for metabolic disease research. The article differentiates itself from standard product pages by offering deep mechanistic context, strategic protocol guidance, and a panoramic view on the future of AMPK-targeted interventions.

• Gramine Induces Ferroptosis in TNBC via CUL3-MTDH Regulation

  2026-06-12

  This study reveals that gramine, a natural indole alkaloid, suppresses triple-negative breast cancer (TNBC) by triggering ferroptosis through modulation of the CUL3-MTDH axis. The findings uncover a novel regulatory mechanism for ferroptosis and highlight gramine's therapeutic promise against aggressive TNBC.

• Mc-Val-Cit-PABC-PNP: Technical Guidance for ADC Synthesis

  2026-06-12

  Mc-Val-Cit-PABC-PNP is a cathepsin B-cleavable ADC peptide linker designed for antibody-drug conjugate workflows that require selective lysosomal payload release. It is optimized for protocols using organic solvents and is unsuitable for applications needing water solubility or clinical/diagnostic use.

• hly Gene Deletion Reduces Biofilm and Antibiotic Resistance

  2026-06-11

  The referenced study demonstrates that deletion of the hly gene in Listeria monocytogenes significantly impairs biofilm formation and increases susceptibility to ribosome-targeting antibiotics. This finding clarifies hly’s regulatory role in biofilm development and antibiotic resistance, suggesting new avenues for controlling Listeria persistence in food environments.

• Amitriptyline HCl: Protocol Parameters and Lab Workflow Guid

  2026-06-11

  Amitriptyline HCl (SKU B2231) is a validated, high-purity tool for studying neurotransmitter receptor modulation in neuropharmacology and mood disorder research. It is optimized for CNS-targeted assays requiring strict solubility, handling, and QC protocols. This compound is not recommended for workflows needing long-term solution storage or applications outside neuropharmacological research.

• Partial BACE1 Inhibition Reduces Amyloid-β Without Synaptic

  2026-06-10

  Satir et al. (2020) demonstrated that moderate inhibition of BACE1, and thus reduction of amyloid-β production by up to 50%, does not impair synaptic transmission in primary neurons. This finding supports the feasibility of partial BACE1 inhibition as a safer therapeutic approach in Alzheimer’s disease research.

• Tiamulin (Thiamutilin): Dual-Action Veterinary Antibiotic In

  2026-06-10

  Tiamulin (Thiamutilin) is a pleuromutilin antibiotic and anti-inflammatory agent with proven efficacy in veterinary medicine. Its mechanism involves selective inhibition of bacterial protein synthesis and modulation of inflammatory signaling. This article details its molecular action, usage benchmarks, and regulatory guidance based on peer-reviewed data.

• Danazol in Bench Research: Applied Protocols & Troubleshooti

  2026-06-09

  Danazol (Danocrine) is a versatile tool for modeling steroidogenesis inhibition and modulating the hypothalamic–pituitary–gonadal axis. This article delivers actionable workflows, protocol refinements, and troubleshooting strategies tailored for endocrine and oncology research, leveraging APExBIO’s high-purity Danazol.

• Z-LEHD-FMK: Strategic Caspase-9 Inhibition for Translational

  2026-06-09

  Explore how Z-LEHD-FMK, a selective irreversible caspase-9 inhibitor, advances translational research through mechanistic insight and protocol innovation. This article bridges mitochondrial apoptosis biology and real-world assay design, integrating evidence from myocardial ischemia/reperfusion models to guide next-generation workflows in cancer and neuroprotection studies.

• Nintedanib (BIBF 1120): Advanced Insights into ATRX-Linked T

  2026-06-08

  Explore how Nintedanib (BIBF 1120) enables precision oncology by exploiting ATRX-deficiency in high-grade glioma and other tumors. This article delivers a deep dive into mechanistic, protocol, and translational considerations beyond standard assay workflows.

• Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) Gu

  2026-06-08

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide high-specificity capture of biotinylated molecules for applications such as protein purification, immunoprecipitation, and nucleic acid isolation. This product is best suited for workflows requiring rapid, low-background separation and is not recommended for protocols incompatible with streptavidin-biotin binding or requiring beads outside the 3 μm size range.

• Electrostatic Partitioning in α-Synuclein Condensates Shapes

  2026-06-07

  This study reveals that α-synuclein condensates formed via liquid–liquid phase separation exhibit a strongly negative electrostatic potential, which governs selective partitioning of proteins and small molecules. The findings highlight electrostatic modulation as a key determinant in biomolecular condensate organization and suggest new strategies for probing these structures in neurodegenerative disease research.

16111 records 1/1075 page Next 12345 下5页 Last page